FINWIRES · TerminalLIVE
FINWIRES

Telix's EPS Forecasts Rise Around 9% for Fiscal 2027, Around 21% for Fiscal 2028 After Glioma Drug Approval, Jefferies Says

By

Telix Pharmaceuticals (ASX:TLX) earnings per share (EPS) forecasts rose by around 9% in fiscal 2027 and around 21% in fiscal 2028 after securing US Food and Drug Administration (FDA) approval for its new drug application for Pixclara, according to a Monday note by Jefferies.

Major changes to the forecasts include an assumption of US reimbursement approval and the beginning of material US sales from the start of fiscal 2027's second half.

Pixclara is an amino acid positron emission tomography (PET) drug for imaging glioma, a type of brain tumor.

It is indicated for use with PET to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and paediatric patients one month of age and older.

The brokerage assigned a buy rating to Telix with a raised price target of AU$30 per share from AU$29.30.

What else is happening in Asia?

Asia

GenFleet Presents Updated Lung Cancer Therapy Data at Korean Medical Conference

GenFleet Therapeutics (HKG:2595) said Tuesday it presented the updated Phase 2 data for GFH375 monotherapy in pretreated KRAS G12D-mutant non-small cell lung cancer at the World Conference on Lung Cancer in South Korea.The company said the updated results showed an objective response rate of 59.2%, a disease control rate of 93%, and a 12-month overall survival rate of 77% in 71 subjects who received 600 milligrams of the oral drug, according to a Tuesday disclosure.

HKG:2595
Asia

White Cliff Minerals Says Gina Rinehart's Hancock Prospecting to Take 13.5% Stake With Nearly AU$9 Million Investment

White Cliff Minerals (ASX:WCN) said Hancock Prospecting agreed to acquire a 13.5% stake in the company through the purchase of about 515.8 million new shares at AU$0.017 each, representing a total investment of roughly AU$8.8 million, according to a Tuesday filing with the Australian bourse.Mining magnate Gina Rinehart is the executive chair of Hancock Prospecting.The private placement is subject to shareholder approval, which White Cliff Minerals will seek at an extraordinary general meeting planned for Oct. 19.If approval is obtained, the completion of the placement is expected three business days after the meeting, per the filing.White Cliff Minerals said it will use the proceeds to expand and fast-track drilling and exploration activities at its Rae copper project in Canada.

ASX:WCN
Asia

Wafangdian Bearing Seeks Delisting As Public Float Falls Below 10%

Wafangdian Bearing (SHE:200706) is looking to terminate its stock listing in Shenzhen following a tender offer, according to a Tuesday filing with the Shenzhen bourse.Up to 1,459 shareholders accepted the tender offer as of Feb. 27, 2026, the bearing manufacturer said in its filing.Following the tender offer, the public float fell to below 10%, falling short of the minimum float required to remain listed, Wafangdian said.

SHE:200706